Publications

Stanco, D., Lipsa, D., Bogni, A., Bremer-Hoffmann, S., & Clerbaux, L.-A. (2024). An Adverse Outcome Pathway for food nanomaterial-induced intestinal barrier disruption. Frontiers in toxicology, 6(1), 1474397. https://doi.org/10.3389/ftox.2024.1474397 (Original work published 2024)

Franco, A., Vieira, D., Clerbaux, L.-A., Orgiazzi, A., Labouyrie, M., Köninger, J., Silva, V., van Dam, R., Carnesecchi, E., Dorne, J. L. C. M., Vuaille, J., Lobo Vicente, J., & Jones, A. (2024). Evaluation of the ecological risk of pesticide residues from the European LUCAS Soil monitoring 2018 survey. Integrated environmental assessment and management, 20(5), 1639-1653. https://doi.org/10.1002/ieam.4917 (Original work published 2024)

Nymark, P., Clerbaux, L.-A., Amorim, M.-J., Andronis, C., de Bernardi, F., Bezemer, G. F. G., Coecke, S., Gavins, F. N. E., Jacobson, D., Lekka, E., Margiotta-Casaluci, L., Martens, M., Mayasich, S. A., Mortensen, H. M., Kim, Y. J., Sachana, M., Tanabe, S., Virvilis, V., Edwards, S. W., & Halappanavar, S. (2024). Building an Adverse Outcome Pathway network for COVID-19. Frontiers in systems biology, 4, 1384481 [1-14]. https://doi.org/10.3389/fsysb.2024.1384481 (Original work published 2024)

Barthe, M., Clerbaux, L.-A., Thénot, J.-P., Braud, V. M., & Osman-Ponchet, H. (2024). Systematic characterization of the barrier function of diverse ex vivo models of damaged human skin. Frontiers, 11. https://doi.org/10.3389/fmed.2024.1481645 (Original work published 2024)

Alb, M., Reiche, K., Rade, M., Sewald, K., Loskill, P., Cipriano, M., Maulana, T. I., van der Meer, A. D., Weener, H. J., Clerbaux, L.-A., Fogal, B., Patel, N., Adkins, K., Lund, E., Perkins, E., Cooper, C., van den Brulle, J., Morgan, H., Rubic-Schneider, T., et al. (2024). Novel strategies to assess cytokine release mediated by chimeric antigen receptor T cells based on the adverse outcome pathway concept. Journal of immunotoxicology, 21(sup1), S13-S28. https://doi.org/10.1080/1547691X.2024.2345158 (Original work published 2024)

Gillard, J., Roumain, M., Picalausa, C., Thibaut, M., Clerbaux, L.-A., Tailleux, A., Staels, B., Muccioli, G., Bindels, L., & Leclercq, I. (2024). A gut microbiota-independent mechanism shapes the bile acid pool in mice with MASH. JHEP Reports, 6(11), 101148 [1-11]. https://doi.org/10.1016/j.jhepr.2024.101148 (Original work published 2024)

Clerbaux, L.-A., Filipovska, J., Nymark, P., Chauhan, V., Sewald, K., Alb, M., Sachana, M., Beronius, A., Amorim, M.-J., & Wittwehr, C. (2024). Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathways. Altex, 41(2), 233-247. https://doi.org/10.14573/altex.2307061 (Original work published 2024)

Neuhaus, V., Clerbaux, L.-A., & Sewald, K. (2024). An overview of immune safety avatar: mimicking the effects of immunomodulatory therapies on the immune system. Journal of immunotoxicology, 21(sup1), S1-S4. https://doi.org/10.1080/1547691X.2024.2354213 (Original work published 2024)

Wittwehr, C., Clerbaux, L.-A., Edwards, S., Angrish, M., Mortensen, H., Carusi, A., Gromelski, M., Lekka, E., Virvilis, V., Martens, M., Bonino da Silva Santos, L. O., & Nymark, P. (2024). Why adverse outcome pathways need to be FAIR. Altex, 41(1), 50-56. https://doi.org/10.14573/altex.2307131 (Original work published 2024)

Clerbaux, L.-A., Cordier, P., Desboeufs, N., Unger, K., Leary, P., Semere, G., Boege, Y., Chan, L. K., Desdouets, C., Lopes, M., & Weber, A. (2023). Mcl-1 deficiency in murine livers leads to nuclear polyploidisation and mitotic errors: Implications for hepatocellular carcinoma. JHEP reports : innovation in hepatology, 5(10), 100838. https://doi.org/10.1016/j.jhepr.2023.100838 (Original work published 2023)

Tanabe, S., Beaton, D., Chauhan, V., Choi, I., Choi, J., Clerbaux, L.-A., Coppola, L., Dumont, A. F., Esterhuizen, M., Filipovska, J., FitzGerald, R., Fritsche, E., Garcia-Reyero, N., Goralczyk, A., Huliganga, E., Kim, Y.-J., Klose, J., La Rocca, C., Landesmann, B., et al. (2023). Report of the 3rd and 4th Mystery of Reactive Oxygen Species Conference. Altex, 40(4), 689-693. https://doi.org/10.14573/altex.2307041 (Original work published 2023)

Carusi, A., Filipovska, J., Wittwehr, C., & Clerbaux, L.-A. (2023). CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway framework. Frontiers in Public Health, 11(1), 1212544. https://doi.org/10.3389/fpubh.2023.1212544 (Original work published 2023)

Gillard, J., Clerbaux, L.-A., Nachit, M., Sempoux, C., Staels, B., Bindels, L., Tailleux, A., & Leclercq, I. (2022). Bile acids contribute to the development of non-alcoholic steatohepatitis in mice. JHEP Reports, 4(1), 100387 [1-13]. https://doi.org/10.1016/j.jhepr.2021.100387 (Original work published 2022)

Clerbaux, L.-A., Mayasich, S. A., Muñoz, A., Soares, H., Petrillo, M., Albertini, M. C., Lanthier, N., Grenga, L., & Amorim, M.-J. (2022). Gut as an Alternative Entry Route for SARS-CoV-2: Current Evidence and Uncertainties of Productive Enteric Infection in COVID-19. Journal of Clinical Medicine, 11(19), 5691 [1-23]. https://doi.org/10.3390/jcm11195691 (Original work published 2022)

Clerbaux, L.-A., Schultz, H., Roman-Holba, S., Ruan, D. F., Yu, R., Lamb, A. M., Bommer, G., & Kennell, J. A. (2021). The microRNA miR-33 is a pleiotropic regulator of metabolic and developmental processes in Drosophila melanogaster. Developmental Dynamics (Online), 250(11), 1634-1650. https://doi.org/10.1002/dvdy.344 (Original work published 2021)